IVRN.US Innoveren Scientific Inc.
- Market cap
- USD 1.86K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is IVRN.US undervalued?
Graham numberThe Graham number of Innoveren Scientific Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Innoveren Scientific Inc. fundamental analysis
No fundamental analysis for Innoveren Scientific Inc. yet.
Innoveren Scientific Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Innoveren Scientific Inc.
Innoveren Scientific Inc., a medical bioscience company that develops technology in regenerative medicine for limb salvage. It is also developing immunotherapies for ovarian cancer, pancreatic cancer, and mesothelioma. The company was formerly known as H-CYTE, Inc. and changed its name to Innoveren Scientific Inc. in July 2023. The company is based in Cincinnati, Ohio.
Full company profileInnoveren Scientific Inc. financial statements
Innoveren Scientific Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 8.35M | 2.15M | 1.61M | 453K | 0.00 |
| Gross Profit | 6.29M | 1.38M | 907K | 336K | -999.00 |
| Operating Income | -15.0M | -7.09M | -5.19M | -3.06M | -2.09M |
| EBITDA | -28.7M | -4.92M | -4.61M | -9.92M | - |
| Net Income | -29.8M | -6.46M | -4.80M | -10.3M | -3.26M |
| EPS | -299 | -51 | -29 | -17 | - |
| Balance Sheet | |||||
| Total Assets | 3.27M | 2.20M | 321K | 137K | - |
| Total Liabilities | 6.67M | 3.25M | 4.98M | 9.49M | - |
| Shareholders' Equity | -3.40M | -1.05M | -4.66M | -9.36M | - |
| Cash & Short-term Investments | 1.42M | 1.64M | 95.2K | 0.00 | - |
| Cash Flow | |||||
| Operating Cash Flow | -12.3M | -7.26M | -4.81M | -1.91M | -918K |
| Capital Expenditure | 20.7K | 2.28K | 7.83K | 0.00 | 0.00 |
| Free Cash Flow | -12.3M | -7.26M | -4.82M | -1.91M | -918K |
| Ratios | |||||
| ROA | -911.4% | -293.0% | -1,493.2% | -7,498.4% | - |
| Net Profit Margin | -357.1% | -300.3% | -297.8% | -2,271.3% | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Innoveren Scientific Inc. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | USD 14.7K | 0.15 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:1000 on Jun 13, 2022.
Who owns Innoveren Scientific Inc.
Ownership data of Innoveren Scientific Inc. is not available yet.
Innoveren Scientific Inc. company profile
- Company name
- Innoveren Scientific Inc.
- Ticker
- IVRN.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 2
- Fiscal year end
- December
- Address
- 132 West Elder Street, Cincinnati, OH, United States, 45202
- Phone
- 844 633 6839
- Website
- innoverenscientific.com
About Innoveren Scientific Inc.
Innoveren Scientific Inc., a medical bioscience company that develops technology in regenerative medicine for limb salvage. It is also developing immunotherapies for ovarian cancer, pancreatic cancer, and mesothelioma. The company was formerly known as H-CYTE, Inc. and changed its name to Innoveren Scientific Inc. in July 2023. The company is based in Cincinnati, Ohio.
Innoveren Scientific Inc. management
2- Mr. Michael W. YurkowskyCEO & Director · born 1972
- Dr. Tanya Rhodes Ph.D.Chief Scientific Officer · born 1961